Viruses and liver cancer | Mosquito vaccine | Coronavirus genomics

June 23, 2020 Edition COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics. Signature of virus exposure may help detect liver cancer A blood test that measures people’s exposure to different viruses identified those who later developed liver cancer. The test could play an important role in improving outcomes for patients. Universal mosquito vaccine tested A small trial showed that a vaccine designed to provide broad protection against mosquito-borne diseases is safe and causes a strong immune response in healthy volunteers. Unique genomic features of fatal coronaviruses A genomic analysis may help explain why some coronaviruses, like SARS-CoV-2, can be deadly, while others cause only mild illness. Popular Stories Novel coronavirus structure reveals targets for vaccines and treatments Study suggests new coronavirus may remain on surfaces for days Llama antibody engineered to block coronavirus Beneficial bacteria prevent recurring bacterial vaginosis How stress causes gray hair